Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	catalytic activity, acting on a nucleic acid	ERCC1 ERCC2 DIS3L2 TDRD9 MARS1 PIWIL2 OGG1 RAD50 EIF4A2 RECQL4 PAN3 METTL2A GEN1 METTL2B	1.43e-04	645	137	14	GO:0140640
GeneOntologyMolecularFunction	tRNA (cytidine-3-)-methyltransferase activity	METTL2A METTL2B	2.78e-04	4	137	2	GO:0052735
GeneOntologyMolecularFunction	mediator complex binding	SMC1A SMC3	2.78e-04	4	137	2	GO:0036033
GeneOntologyBiologicalProcess	cell cycle process	ERCC2 DIS3L2 HUS1B ATR TDRD9 CLASP1 NOP53 PPP1R12A SMC1A PIWIL2 STOX1 TUBGCP5 RAD50 PPP1R7 EGF FBXO5 SMC3 RPTOR RECQL4 PKD1 ASPM FES TIMELESS GEN1 IQGAP3 DYNC1H1 NIN	7.90e-07	1441	137	27	GO:0022402
GeneOntologyBiologicalProcess	meiotic cell cycle	HUS1B TDRD9 SMC1A PIWIL2 TUBGCP5 RAD50 FBXO5 SMC3 PRKACA PRKACB ASPM	2.26e-05	350	137	11	GO:0051321
GeneOntologyBiologicalProcess	microtubule-based process	ERBB2 CFAP91 CLASP1 PPP1R12A SMC1A CNTRL CFAP43 TUBGCP5 DNALI1 NPHP3 FBXO5 SMC3 MID1 PKD1 ASPM FES GEN1 DYNC1H1 AGTPBP1 NIN	2.28e-05	1058	137	20	GO:0007017
GeneOntologyBiologicalProcess	microtubule cytoskeleton organization	CFAP91 CLASP1 PPP1R12A SMC1A CNTRL CFAP43 TUBGCP5 FBXO5 SMC3 MID1 PKD1 ASPM FES GEN1 DYNC1H1 NIN	2.40e-05	720	137	16	GO:0000226
GeneOntologyBiologicalProcess	mitotic recombination	ERCC1 ERCC2 RAD50 GEN1	2.90e-05	27	137	4	GO:0006312
GeneOntologyBiologicalProcess	mitotic cell cycle	ERCC2 DIS3L2 HUS1B ATR CLASP1 NOP53 PPP1R12A SMC1A STOX1 TUBGCP5 RAD50 EGF FBXO5 SMC3 RPTOR PKD1 GEN1 IQGAP3 DYNC1H1	4.20e-05	1014	137	19	GO:0000278
GeneOntologyBiologicalProcess	mitotic cell cycle process	ERCC2 DIS3L2 HUS1B ATR CLASP1 NOP53 SMC1A STOX1 RAD50 EGF FBXO5 SMC3 RPTOR PKD1 GEN1 IQGAP3 DYNC1H1	5.26e-05	854	137	17	GO:1903047
GeneOntologyBiologicalProcess	spindle assembly	CLASP1 SMC1A TUBGCP5 FBXO5 SMC3 ASPM DYNC1H1	7.40e-05	153	137	7	GO:0051225
GeneOntologyBiologicalProcess	organelle fission	SEC16B DIS3L2 TDRD9 CLASP1 SMC1A PIWIL2 STAT2 RAD50 EGF FBXO5 SMC3 ASPM GEN1	1.14e-04	571	137	13	GO:0048285
GeneOntologyBiologicalProcess	regulation of G2/M transition of mitotic cell cycle	HUS1B ATR NOP53 STOX1 RAD50 FBXO5	1.25e-04	116	137	6	GO:0010389
GeneOntologyBiologicalProcess	spindle organization	CLASP1 SMC1A TUBGCP5 FBXO5 SMC3 PKD1 ASPM DYNC1H1	1.28e-04	224	137	8	GO:0007051
GeneOntologyBiologicalProcess	mitotic cell cycle phase transition	ERCC2 HUS1B ATR CLASP1 NOP53 STOX1 RAD50 FBXO5 RPTOR PKD1 GEN1 IQGAP3	1.53e-04	509	137	12	GO:0044772
GeneOntologyBiologicalProcess	transcription by RNA polymerase I	ERBB2 ERCC2 MARS1 NOP53 UTP15	1.83e-04	79	137	5	GO:0006360
GeneOntologyBiologicalProcess	organelle assembly	CFAP91 CLASP1 NOP53 SMC1A CNTRL CFAP43 TUBGCP5 DNALI1 NPHP3 TBC1D31 CLCN4 FBXO5 AP1G1 SMC3 CASKIN1 ASPM PAN3 DYNC1H1 MYBPC2	1.91e-04	1138	137	19	GO:0070925
GeneOntologyBiologicalProcess	regulation of meiotic cell cycle	PIWIL2 FBXO5 PRKACA PRKACB ASPM	2.18e-04	82	137	5	GO:0051445
GeneOntologyBiologicalProcess	regulation of cell cycle G2/M phase transition	HUS1B ATR NOP53 STOX1 RAD50 FBXO5	2.44e-04	131	137	6	GO:1902749
GeneOntologyBiologicalProcess	establishment of meiotic sister chromatid cohesion	SMC1A SMC3	2.60e-04	4	137	2	GO:0034089
GeneOntologyBiologicalProcess	chromosome segregation	ERCC2 DIS3L2 CLASP1 SMC1A TUBGCP5 PPP1R7 FBXO5 SMC3 ASPM GEN1 DYNC1H1	2.81e-04	465	137	11	GO:0007059
GeneOntologyBiologicalProcess	cell cycle phase transition	ERCC2 HUS1B ATR CLASP1 NOP53 STOX1 RAD50 FBXO5 RPTOR PKD1 TIMELESS GEN1 IQGAP3	2.84e-04	627	137	13	GO:0044770
GeneOntologyBiologicalProcess	regulation of transcription by RNA polymerase I	ERBB2 MARS1 NOP53 UTP15	3.38e-04	50	137	4	GO:0006356
GeneOntologyBiologicalProcess	regulation of mitotic cell cycle phase transition	ERCC2 HUS1B ATR NOP53 STOX1 RAD50 FBXO5 RPTOR PKD1 GEN1	3.61e-04	402	137	10	GO:1901990
GeneOntologyCellularComponent	mitotic spindle pole	SMC1A CNTRL SMC3 ASPM NIN	9.17e-06	43	138	5	GO:0097431
GeneOntologyCellularComponent	ciliary base	DNALI1 NPHP3 CLCN4 PRKACA PRKACB	3.40e-05	56	138	5	GO:0097546
GeneOntologyCellularComponent	centrosome	CLASP1 PPP1R12A CNTRL STOX1 TUBGCP5 TBC1D31 CEP112 MID1 PRKACA PRKACB ASPM ZBED1 GEN1 DYNC1H1 NIN	1.77e-04	770	138	15	GO:0005813
GeneOntologyCellularComponent	meiotic spindle	CNTRL FBXO5 ASPM	2.52e-04	19	138	3	GO:0072687
GeneOntologyCellularComponent	microtubule organizing center	CLASP1 PPP1R12A CNTRL STOX1 TUBGCP5 TBC1D31 CEP112 MID1 PRKACA PRKACB ASPM ZBED1 USH2A GEN1 DYNC1H1 NIN	3.77e-04	919	138	16	GO:0005815
GeneOntologyCellularComponent	cytoplasmic region	CFAP91 CLASP1 CNTRL CFAP43 DNALI1 GUCY1B1 PRKACA DYNC1H1 AGTPBP1	6.59e-04	360	138	9	GO:0099568
GeneOntologyCellularComponent	cilium	EPS15 CFAP91 IMPG1 CNTRL CFAP43 DNALI1 NPHP3 TBC1D31 CLCN4 PKD1 PRKACA PRKACB USH2A CFAP99 NIN	8.84e-04	898	138	15	GO:0005929
GeneOntologyCellularComponent	meiotic cohesin complex	SMC1A SMC3	8.89e-04	7	138	2	GO:0030893
GeneOntologyCellularComponent	mitotic cohesin complex	SMC1A SMC3	8.89e-04	7	138	2	GO:0030892
GeneOntologyCellularComponent	clathrin adaptor complex	EPS15 AP2A2 AP1G1	1.11e-03	31	138	3	GO:0030131
GeneOntologyCellularComponent	spindle	ERCC2 CLASP1 SMC1A CNTRL TUBGCP5 FBXO5 SMC3 MID1 ASPM NIN	1.16e-03	471	138	10	GO:0005819
Domain	-	ATR CLASP1 KPNA6 SIL1 PPP2R5E AP2A2 AP1G1 RPTOR ASPM RIC8A WDFY3 AGTPBP1	6.96e-08	222	134	12	1.25.10.10
Domain	ARM-like	ATR CLASP1 KPNA6 SIL1 PPP2R5E AP2A2 AP1G1 RPTOR ASPM RIC8A WDFY3 AGTPBP1	5.76e-07	270	134	12	IPR011989
Domain	ARM-type_fold	ATR CLASP1 KPNA6 SIL1 PPP2R5E AP2A2 AP1G1 RPTOR ASPM RIC8A WDFY3 AGTPBP1	6.12e-06	339	134	12	IPR016024
Domain	RecF/RecN/SMC_N	SMC1A RAD50 SMC3	1.97e-05	8	134	3	IPR003395
Domain	SMC_N	SMC1A RAD50 SMC3	1.97e-05	8	134	3	PF02463
Domain	IQ	MYO10 MYO5C MYH14 ASPM IQGAP3	1.57e-04	71	134	5	PF00612
Domain	IQ	MYO10 MYO5C MYH14 ASPM IQGAP3	2.92e-04	81	134	5	SM00015
Domain	MeTrfase	METTL2A METTL2B	3.04e-04	4	134	2	IPR026113
Domain	Myosin-like_IQ_dom	MYO5C MYH14 ASPM	3.22e-04	19	134	3	IPR027401
Domain	-	MYO5C MYH14 ASPM	3.22e-04	19	134	3	4.10.270.10
Domain	IQ_motif_EF-hand-BS	MYO10 MYO5C MYH14 ASPM IQGAP3	4.76e-04	90	134	5	IPR000048
Domain	SMC	SMC1A SMC3	5.04e-04	5	134	2	IPR024704
Domain	IQ	MYO10 MYO5C MYH14 ASPM IQGAP3	5.53e-04	93	134	5	PS50096
Domain	WD40	FBXW10B FBXW10 GRWD1 CFAP43 TBC1D31 UTP15 RPTOR WDFY3	7.11e-04	268	134	8	SM00320
Domain	SMC_hinge	SMC1A SMC3	7.52e-04	6	134	2	SM00968
Domain	Methyltransf_12	METTL2A METTL2B	7.52e-04	6	134	2	IPR013217
Domain	Methyltransf_12	METTL2A METTL2B	7.52e-04	6	134	2	PF08242
Domain	SMC_hinge	SMC1A SMC3	7.52e-04	6	134	2	PF06470
Domain	SMC_hinge	SMC1A SMC3	7.52e-04	6	134	2	IPR010935
Domain	WD40_repeat	FBXW10B FBXW10 GRWD1 CFAP43 TBC1D31 UTP15 RPTOR WDFY3	7.83e-04	272	134	8	IPR001680
Domain	WD_REPEATS_1	FBXW10B FBXW10 GRWD1 CFAP43 TBC1D31 UTP15 RPTOR WDFY3	9.02e-04	278	134	8	PS00678
Domain	WD_REPEATS_2	FBXW10B FBXW10 GRWD1 CFAP43 TBC1D31 UTP15 RPTOR WDFY3	9.23e-04	279	134	8	PS50082
Domain	WD_REPEATS_REGION	FBXW10B FBXW10 GRWD1 CFAP43 TBC1D31 UTP15 RPTOR WDFY3	9.23e-04	279	134	8	PS50294
Domain	HHH	ERCC1 OGG1	1.05e-03	7	134	2	PF00633
Domain	HhH_motif	ERCC1 OGG1	1.05e-03	7	134	2	IPR000445
Domain	WD40_repeat_CS	FBXW10B FBXW10 GRWD1 TBC1D31 UTP15 WDFY3	1.19e-03	164	134	6	IPR019775
Pubmed	Novel asymmetrically localizing components of human centrosomes identified by complementary proteomics methods.	CLASP1 CNTRL TUBGCP5 TBC1D31 CEP112 PRKACA PRKACB DYNC1H1 NIN	8.14e-09	146	139	9	21399614
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	EPS15 ACADVL RANBP3 PPP1R12A SMC1A MATR3 RAD50 ESYT2 PPP2R5E AP2A2 AP1G1 SMC3 RPTOR TIMELESS DYNC1H1	8.23e-09	560	139	15	35241646
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	USP36 TRAF1 GRWD1 ATR MARS1 NOP53 SMC1A MATR3 BIRC3 RPS18 KPNA6 RAD50 SLC25A22 AP2A2 AP1G1 SMC3 UTP15 MYH14 RPTOR PRKACA IQGAP3 RPL7 DYNC1H1	1.18e-08	1425	139	23	30948266
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	GRWD1 MYO10 MARS1 NOP53 PPP1R12A SMC1A MATR3 RPS18 HP1BP3 MYO5C SLC25A22 AP2A2 SMC3 UTP15 MYH14 PLEKHG3 RPL7 DYNC1H1	5.02e-08	949	139	18	36574265
Pubmed	The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability.	MYO10 RBM10 PPP1R12A MATR3 RPS18 MYO5C RAD50 AP2A2 MYH14 PAN3 RPL7	9.49e-08	328	139	11	23398456
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	USP36 DIS3L2 MARS1 SMC1A MATR3 RPS18 RAD50 SLC25A22 AP2A2 AP1G1 SMC3 UTP15 MYH14 PLEKHG3 RPTOR RECQL4 ASPM RIC8A WDFY3 RPL7 DYNC1H1	1.06e-07	1353	139	21	29467282
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	EPS15 MARS1 RBM10 PPP1R12A SMC1A MATR3 RPS18 KPNA6 RAD50 PPP1R7 AP2A2 SMC3 EIF4A2 XPNPEP3 MID1 PRKACA IQGAP3 RPL7 DYNC1H1	1.75e-07	1149	139	19	35446349
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	EPS15 CLASP1 TROAP PPP1R12A SMC1A MATR3 KPNA6 TUBGCP5 OGG1 PPP1R7 PPP2R5E FBXO5 SMC3 EIF4A2 RECQL4 ASPM TIMELESS IQGAP3 DYNC1H1	1.89e-07	1155	139	19	20360068
Pubmed	GPCR signaling inhibits mTORC1 via PKA phosphorylation of Raptor.	RPTOR PRKACA PRKACB	2.49e-07	4	139	3	31112131
Pubmed	GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system.	GRWD1 MARS1 MATR3 RPS18 HP1BP3 SLC25A22 ESYT2 RPL7 DYNC1H1	2.88e-07	221	139	9	29991511
Pubmed	Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk.	ERCC1 ERCC2 OGG1	6.21e-07	5	139	3	18478337
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	EPS15 ERCC2 FBXW10 GRWD1 CLASP1 MYO10 RPS18 STAT2 HP1BP3 AP1G1 UTP15 RPTOR PRKACA PRKACB SNAPC2 PAN3 AGTPBP1	9.35e-07	1038	139	17	26673895
Pubmed	Nucleolar proteome dynamics.	USP36 ERCC2 GRWD1 ATR NOP53 SMC1A RPS18 RAD50 SMC3 RPL7 DYNC1H1	1.07e-06	419	139	11	15635413
Pubmed	A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells.	ERCC2 ATR MARS1 FFAR3 SMC1A RPS18 FBXO5 SMC3 RPTOR ASPM RPL7	1.07e-06	419	139	11	28700943
Pubmed	Polymorphisms of DNA repair genes and risk of non-small cell lung cancer.	ERCC1 ERCC2 ATR OGG1	1.13e-06	20	139	4	16195237
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	GRWD1 MARS1 PPP1R12A MATR3 CNTRL SHROOM2 NPHP3 THOP1 PPP2R5E TBC1D31 AP1G1 PTPRR CEP112 EIF4A2 TIMELESS PAN3 GEN1	1.68e-06	1084	139	17	11544199
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	NR2F6 ERBB2 FRAS1 ERCC2 MYO10 ICE1 CFAP43 SIL1 SLC25A22 PLA2G4B RPTOR CASKIN1 PKD1 RIC8A WDFY3 IQGAP3 DYNC1H1	2.18e-06	1105	139	17	35748872
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	USP36 ERBB2 ERCC2 PPP1R12A KPNA6 TUBGCP5 RAD50 SLC25A22 PPP2R5E FBXO5 RPTOR ASPM RIC8A TRAF3IP3 WDFY3 AGTPBP1 NIN	2.49e-06	1116	139	17	31753913
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	USP36 ERCC1 BAZ2B SMC1A RAD50 AP2A2 SMC3 IQGAP3	3.34e-06	222	139	8	37071664
Pubmed	Comprehensive analysis of DNA repair gene polymorphisms and survival in patients with early stage non-small-cell lung cancer.	ERCC1 ERCC2 ATR OGG1	3.41e-06	26	139	4	20731661
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	GRWD1 CLASP1 ACADVL MARS1 SMC1A MATR3 RPS18 KPNA6 HP1BP3 RAD50 SLC25A22 THOP1 AP2A2 AP1G1 SMC3 XPNPEP3 RPL7 DYNC1H1 METTL2B	3.84e-06	1415	139	19	28515276
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CLASP1 MARS1 PPP1R12A MATR3 RPS18 SHROOM2 HP1BP3 PPP1R7 SLC25A22 PPP2R5E AP2A2 AP1G1 MYH14 RPTOR CASKIN1 PRKACA RPL7 DYNC1H1 AGTPBP1	4.52e-06	1431	139	19	37142655
Pubmed	Genetic link between renal birth defects and congenital heart disease.	FRAS1 CNTRL PKD1 ROBO1	4.64e-06	28	139	4	27002738
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	EFCAB5 ACADVL PPP1R12A MATR3 CNTRL STOX1 HP1BP3 SLC25A22 TBC1D31 CLCN4 AP2A2 MYH14 CEP112 EIF4A2 PRKACA PRKACB ASPM OTUD3 MYBPC2	5.04e-06	1442	139	19	35575683
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	ERCC2 RPS18 KPNA6 RAD50 SLC25A22 AP1G1 SMC3 UTP15 EIF4A2 RIC8A TIMELESS IQGAP3 DYNC1H1	5.41e-06	704	139	13	29955894
Pubmed	STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production.	GRWD1 MARS1 NOP53 RBM10 MATR3 AP2A2 PRKACA ASPM RPL7	5.49e-06	316	139	9	31665637
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	EPS15 MARS1 RANBP3 PPP1R12A SMC1A LDHAL6B RPS18 KPNA6 SCLY PPP1R7 THOP1 PPP2R5E AP1G1 MYH14 PRKACA PRKACB RIC8A TIMELESS DYNC1H1	5.73e-06	1455	139	19	22863883
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	ERBB2 RBM10 SMC1A MATR3 RPS18 HP1BP3 RAD50 AP1G1 MYH14 RIC8A RPL7 DYNC1H1	5.78e-06	601	139	12	33658012
Pubmed	Nuclear lamina genetic variants, including a truncated LAP2, in twins and siblings with nonalcoholic fatty liver disease.	MARS1 MATR3 RPS18 SLC25A22 AP2A2 MYH14 EIF4A2 RPL7	6.68e-06	244	139	8	28902428
Pubmed	Centrosomal proteins CG-NAP and kendrin provide microtubule nucleation sites by anchoring gamma-tubulin ring complex.	CLASP1 CNTRL TUBGCP5 PRKACA DYNC1H1	6.97e-06	66	139	5	12221128
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	EPS15 CLASP1 PPP1R12A MATR3 RAD50 PPP1R7 AP2A2 RPTOR CASKIN1 SPHKAP EIF4A2 PRKACA PRKACB WDFY3 DYNC1H1	7.76e-06	963	139	15	28671696
Pubmed	Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk.	ERCC1 ERCC2 ATR OGG1 RAD50	8.08e-06	68	139	5	20496165
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	ATR RBM10 PPP1R12A SMC1A MATR3 RAD50 AP2A2 SMC3 RPL7	9.87e-06	340	139	9	24332808
Pubmed	Polymorphic DNA repair and metabolic genes: a multigenic study on gastric cancer.	ERCC1 ERCC2 OGG1	1.01e-05	11	139	3	20817763
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	GRWD1 MARS1 SMC1A RPS18 KPNA6 RAD50 ESYT2 AP1G1 SMC3 RIC8A RPL7 DYNC1H1	1.05e-05	638	139	12	33239621
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	GRWD1 CLASP1 NOP53 SMC1A MATR3 RPS18 HP1BP3 SMC3 UTP15 ASPM IQGAP3 RPL7 AGTPBP1	1.20e-05	759	139	13	35915203
Pubmed	A Large-scale genetic association study of esophageal adenocarcinoma risk.	ERBB2 ERCC1 ERCC2 HUS1B ATR BIRC3 OGG1 GHRHR EGF	1.27e-05	351	139	9	20453000
Pubmed	A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer.	ERBB2 ERCC1 ERCC2 OGG1 EGF	1.31e-05	75	139	5	20644561
Pubmed	Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients.	ERCC1 ERCC2 EGF	1.34e-05	12	139	3	16407418
Pubmed	International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways.	ERCC1 ERCC2 OGG1	1.34e-05	12	139	3	18990748
Pubmed	A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility.	ERCC1 ERCC2 ATR OGG1	1.46e-05	37	139	4	19116388
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	CLASP1 MARS1 RANBP3 PPP1R12A SMC1A MATR3 KPNA6 OGG1 RAD50 PPP1R7 SLC25A22 SMC3 EIF4A2 PRKACA ASPM FES DYNC1H1	1.55e-05	1284	139	17	17353931
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ERCC1 CFAP91 SMC1A KPNA6 SHROOM2 TUBGCP5 THOP1 PPP2R5E GUCY1B1 MYH14 EIF4A2 PKD1 ROBO1 WDFY3 GEN1 DYNC1H1 AGTPBP1	1.57e-05	1285	139	17	35914814
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	ACADVL MARS1 RBM10 RANBP3 SMC1A MATR3 HP1BP3 AP2A2 CEP112 PRKACA PRKACB DYNC1H1	1.59e-05	665	139	12	30457570
Pubmed	DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck.	ERCC1 ERCC2	1.59e-05	2	139	2	12220217
Pubmed	Genetic polymorphisms and haplotypes of ERCC1 and ERCC2 associated with quality of life, depression, and anxiety status among patients with lung cancer.	ERCC1 ERCC2	1.59e-05	2	139	2	34284736
Pubmed	Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase.	PRKACA PRKACB	1.59e-05	2	139	2	3023318
Pubmed	Association of ERCC1 C8092A and ERCC2 Lys751Gln polymorphisms with the risk of glioma: a meta-analysis.	ERCC1 ERCC2	1.59e-05	2	139	2	24763305
Pubmed	Common polymorphisms in the XPD and hOGG1 genes are not associated with the risk of colorectal cancer in a Polish population.	ERCC2 OGG1	1.59e-05	2	139	2	19561388
Pubmed	Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival.	ERCC1 ERCC2	1.59e-05	2	139	2	32397974
Pubmed	ERCC1 and ERCC2 haplotype modulates induced BPDE-DNA adducts in primary cultured lymphocytes.	ERCC1 ERCC2	1.59e-05	2	139	2	23593158
Pubmed	Protein expression levels of excision repair cross-complementation group 1 and xeroderma pigmentosum D correlate with response to platinum-based chemotherapy in the patients with advanced epithelial ovarian cancer.	ERCC1 ERCC2	1.59e-05	2	139	2	18081788
Pubmed	Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum.	ERCC1 ERCC2	1.59e-05	2	139	2	29572009
Pubmed	Genetic variability of ERCC1 and ERCC2 influences treatment outcomes in gastric cancer.	ERCC1 ERCC2	1.59e-05	2	139	2	26782397
Pubmed	Mutations in cohesin complex members SMC3 and SMC1A cause a mild variant of cornelia de Lange syndrome with predominant mental retardation.	SMC1A SMC3	1.59e-05	2	139	2	17273969
Pubmed	CEP110 and ninein are located in a specific domain of the centrosome associated with centrosome maturation.	CNTRL NIN	1.59e-05	2	139	2	11956314
Pubmed	Polymorphisms of DNA repair genes OGG1 and XPD and the risk of age-related cataract in Egyptians.	ERCC2 OGG1	1.59e-05	2	139	2	24868140
Pubmed	Replisome dysfunction upon inducible TIMELESS degradation synergizes with ATR inhibition to trigger replication catastrophe.	ATR TIMELESS	1.59e-05	2	139	2	37144518
Pubmed	Direct downregulation of CNTNAP2 by STOX1A is associated with Alzheimer's disease.	STOX1 CNTNAP2	1.59e-05	2	139	2	22728895
Pubmed	A positively charged channel within the Smc1/Smc3 hinge required for sister chromatid cohesion.	SMC1A SMC3	1.59e-05	2	139	2	21139566
Pubmed	The neuropeptide processing enzyme EC 3.4.24.15 is modulated by protein kinase A phosphorylation.	THOP1 PRKACA	1.59e-05	2	139	2	10969067
Pubmed	Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.	ERCC1 ERCC2	1.59e-05	2	139	2	26191265
Pubmed	Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes.	ERCC1 ERCC2	1.59e-05	2	139	2	19620936
Pubmed	Cornelia de Lange syndrome mutations in SMC1A or SMC3 affect binding to DNA.	SMC1A SMC3	1.59e-05	2	139	2	18996922
Pubmed	RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma.	RBM10 ASPM	1.59e-05	2	139	2	38576051
Pubmed	Use a survival model to correlate single-nucleotide polymorphisms of DNA repair genes with radiation dose-response in patients with non-small cell lung cancer.	ERCC1 ERCC2	1.59e-05	2	139	2	26253951
Pubmed	ERCC1 and XPD/ERCC2 polymorphisms' predictive value of oxaliplatin-based chemotherapies in advanced colorectal cancer has an ethnic discrepancy: a meta-analysis.	ERCC1 ERCC2	1.59e-05	2	139	2	24833529
Pubmed	The association between the ERCC1/2 polymorphisms and the clinical outcomes of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis.	ERCC1 ERCC2	1.59e-05	2	139	2	24338713
Pubmed	Genetic variability of ERCC1 and ERCC2 genes involved in the nucleotide excision repair pathway influences the treatment outcome of gastric cancer.	ERCC1 ERCC2	1.59e-05	2	139	2	27173253
Pubmed	Systematic review on the association between ERCC1 rs3212986 and ERCC2 rs13181 polymorphisms and glioma risk.	ERCC1 ERCC2	1.59e-05	2	139	2	25867436
Pubmed	Investigation of -PRKACA/-PRKACB fusion genes in oncocytic tumors of the pancreatobiliary and other systems.	PRKACA PRKACB	1.59e-05	2	139	2	36152045
Pubmed	Association of ERCC gene polymorphism with osteosarcoma risk.	ERCC1 ERCC2	1.59e-05	2	139	2	34394247
Pubmed	PRKACA/PRKACB Fusions in Pancreatobiliary Intraductal Oncocytic Papillary Neoplasms Including Those With Atypical Morphology: An Analysis of 22 Cases Expanding Morphologic Spectrum.	PRKACA PRKACB	1.59e-05	2	139	2	38841868
Pubmed	Association between ERCC1 and ERCC2 gene polymorphisms and susceptibility to pancreatic cancer.	ERCC1 ERCC2	1.59e-05	2	139	2	27051038
Pubmed	Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population.	ERCC1 ERCC2	1.59e-05	2	139	2	24531312
Pubmed	Twelve single nucleotide polymorphisms on chromosome 19q13.2-13.3: linkage disequilibria and associations with basal cell carcinoma in Danish psoriatic patients.	ERCC1 ERCC2	1.59e-05	2	139	2	12645871
Pubmed	ERCC1 and ERCC2 as predictive biomarkers to oxaliplatin-based chemotherapy in colorectal cancer patients from Egypt.	ERCC1 ERCC2	1.59e-05	2	139	2	28088319
Pubmed	Association between ERCC1 C8092A and ERCC2 K751Q polymorphisms and risk of adult glioma: a meta-analysis.	ERCC1 ERCC2	1.59e-05	2	139	2	24254311
Pubmed	Polymorphisms in XPD and hOGG1 and prostate cancer risk: a meta-analysis.	ERCC2 OGG1	1.59e-05	2	139	2	22890093
Pubmed	HapMap-based study of a region encompassing ERCC1 and ERCC2 related to lung cancer susceptibility in a Chinese population.	ERCC1 ERCC2	1.59e-05	2	139	2	21601580
Pubmed	Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis.	ERCC1 ERCC2	1.59e-05	2	139	2	20143185
Pubmed	Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzo[a]pyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: a genotype-phenotype correlation analysis.	ERCC1 ERCC2	1.59e-05	2	139	2	18635523
Pubmed	Association of four ERCC1 and ERCC2 SNPs with survival of bone tumour patients.	ERCC1 ERCC2	1.59e-05	2	139	2	23098477
Pubmed	Molecular and behavioral effects of a null mutation in all PKA C beta isoforms.	PRKACA PRKACB	1.59e-05	2	139	2	12139926
Pubmed	Association of NER pathway gene polymorphisms with susceptibility to laryngeal cancer in a Chinese population.	ERCC1 ERCC2	1.59e-05	2	139	2	26617899
Pubmed	Polymorphism of DNA repair genes OGG1, XRCC1, XPD and ERCC6 in bladder cancer in Belarus.	ERCC2 OGG1	1.59e-05	2	139	2	25089939
Pubmed	Association of ERCC1 and ERCC2 Gene Polymorphisms with Pancreatic Cancer Risk: A Meta-Analysis.	ERCC1 ERCC2	1.59e-05	2	139	2	32749109
Pubmed	ERCC1 and ERCC2 polymorphisms and adult glioma.	ERCC1 ERCC2	1.59e-05	2	139	2	16212814
Pubmed	Polymorphisms in ERCC1 and ERCC2/XPD genes and carcinogen DNA adducts in human lung.	ERCC1 ERCC2	1.59e-05	2	139	2	26001533
Pubmed	Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy.	ERCC1 ERCC2	1.59e-05	2	139	2	15140544
Pubmed	No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: a meta-analysis.	ERCC1 ERCC2	1.59e-05	2	139	2	21075476
Pubmed	Characterization of genomic clones coding for the C alpha and C beta subunits of mouse cAMP-dependent protein kinase.	PRKACA PRKACB	1.59e-05	2	139	2	2833513
Pubmed	Association of hOGG1 and XPD polymorphisms with urothelial carcinoma in Taiwan.	ERCC2 OGG1	1.59e-05	2	139	2	22110223
Pubmed	The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients.	ERCC1 ERCC2	1.59e-05	2	139	2	29980176
Pubmed	Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy.	ERCC1 ERCC2	1.59e-05	2	139	2	26823845
Pubmed	ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis.	ERCC1 ERCC2	1.59e-05	2	139	2	21278243
Pubmed	ATR pathway inhibition is synthetically lethal in cancer cells with ERCC1 deficiency.	ERCC1 ATR	1.59e-05	2	139	2	24662920
Pubmed	Association between ERCC1 and ERCC2 gene polymorphisms and chemotherapy response and overall survival in osteosarcoma.	ERCC1 ERCC2	1.59e-05	2	139	2	26345951
Pubmed	Global consequences of activation loop phosphorylation on protein kinase A.	PRKACA PRKACB	1.59e-05	2	139	2	19965870
Pubmed	Genetic polymorphisms in ERCC1 and ERCC2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis.	ERCC1 ERCC2	1.59e-05	2	139	2	28388903
Interaction	KIF23 interactions	NDNF GRWD1 ACADVL MARS1 PPP1R12A MATR3 BIRC3 RPS18 MYO5C SLC25A22 FBXO5 UTP15 MYH14 EIF4A2 XPNPEP3 ASPM CNTNAP4 TTC22 GEN1 IQGAP3 RPL7 DYNC1H1 NIN	3.98e-07	1031	136	23	int:KIF23
Interaction	MST1R interactions	ERBB2 ATR SMC1A HP1BP3 RAD50 SMC3 PTPRR FES ZBED1 DYNC1H1	1.06e-06	200	136	10	int:MST1R
Interaction	GRWD1 interactions	USP36 GRWD1 MARS1 MATR3 BIRC3 RPS18 HP1BP3 SLC25A22 ESYT2 PTPRR RECQL4 RPL7 DYNC1H1	2.47e-06	390	136	13	int:GRWD1
Interaction	PPP1CA interactions	ATR ACADVL NOP53 PPP1R12A MATR3 BIRC3 RPS18 MYO5C RAD50 PPP1R7 PPP2R5E RECQL4 PRKACA PRKACB ASPM RPL7 DYNC1H1	4.66e-06	696	136	17	int:PPP1CA
Interaction	CRY2 interactions	TRAF1 MARS1 MATR3 KPNA6 PPP2R5E EIF4A2 MID1 TIMELESS DYNC1H1	6.89e-06	194	136	9	int:CRY2
Interaction	DNAJA3 interactions	USP36 ERBB2 GRWD1 ACADVL BIRC3 RPS18 PTPRR RPTOR RECQL4 PRKACA DYNC1H1 NIN	8.08e-06	370	136	12	int:DNAJA3
Interaction	AURKB interactions	NOP53 PPP1R12A SMC1A MATR3 CNTRL RPS18 RAD50 SLC25A22 MYH14 PLEKHG3 XPNPEP3 CNTNAP4 RIC8A TIMELESS LY86 RPL7 DYNC1H1	1.49e-05	761	136	17	int:AURKB
Interaction	C9orf78 interactions	EPS15 ACADVL RANBP3 PPP1R12A SMC1A MATR3 RAD50 ESYT2 PPP2R5E AP2A2 AP1G1 SMC3 RPTOR TIMELESS DYNC1H1	1.97e-05	620	136	15	int:C9orf78
Interaction	PRC1 interactions	BAZ2B MARS1 RBM10 PPP1R12A MATR3 BIRC3 RPS18 PIWIL2 HP1BP3 AP2A2 UTP15 EIF4A2 XPNPEP3 CNTNAP4 RIC8A PAN3 IQGAP3 RPL7 DYNC1H1	2.96e-05	973	136	19	int:PRC1
Interaction	BRCA1 interactions	ERCC1 ERCC2 ATR MID2 TROAP MARS1 FAAP24 SMC1A MATR3 RPS18 KPNA6 HP1BP3 RAD50 FBXO5 SMC3 MYH14 RPTOR EIF4A2 RECQL4 USH2A RPL7 DYNC1H1	3.18e-05	1249	136	22	int:BRCA1
Interaction	EPS15L1 interactions	EPS15 SMC1A AP2A2 SMC3 GNG5 IQGAP3 STX6	4.24e-05	138	136	7	int:EPS15L1
Interaction	SGO1 interactions	CLASP1 SMC1A PPP2R5E TBC1D31 TIMELESS OTUD3 RPL7	4.24e-05	138	136	7	int:SGO1
Interaction	PLK1 interactions	EPS15 ERCC1 PPP1R12A SMC1A CNTRL FBXO5 SMC3 RPTOR RECQL4 ASPM TIMELESS AGTPBP1 NIN	4.27e-05	510	136	13	int:PLK1
Interaction	MAPRE1 interactions	EPS15 CLASP1 TROAP MYO10 PPP1R12A BIRC3 HP1BP3 TBC1D31 PRKACA PRKACB RPL7 DYNC1H1 NIN	4.62e-05	514	136	13	int:MAPRE1
Interaction	IQGAP1 interactions	EPS15 GRWD1 PPP1R12A MATR3 BIRC3 MYO5C AP2A2 SMC3 PLEKHG3 RPTOR RECQL4 PRKACA DYNC1H1 NIN	4.75e-05	591	136	14	int:IQGAP1
Interaction	EPN2 interactions	EPS15 MID2 RAD50 THOP1 MID1 STX6	5.66e-05	99	136	6	int:EPN2
Interaction	TNIP1 interactions	NDNF TRAF1 GRWD1 MYO10 MARS1 NOP53 PPP1R12A SMC1A MATR3 RPS18 HP1BP3 MYO5C SLC25A22 AP2A2 SMC3 UTP15 MYH14 PLEKHG3 HAO2 RPL7 DYNC1H1	6.61e-05	1217	136	21	int:TNIP1
Interaction	KCNA3 interactions	EPS15 ERBB2 MARS1 SMC1A RPS18 MYO5C RAD50 ESYT2 FBXO5 SMC3 CEP112 RPTOR MID1 ROBO1 IQGAP3 RPL7 DYNC1H1	8.09e-05	871	136	17	int:KCNA3
Interaction	PAN2 interactions	MYO10 RBM10 PPP1R12A MATR3 RPS18 MYO5C RAD50 AP2A2 MYH14 PAN3 RPL7	8.14e-05	397	136	11	int:PAN2
Interaction	TUBB4B interactions	USP36 TRAF1 MID2 CLASP1 PPP1R12A SMC1A CNTRL RPTOR RECQL4 MID1 RPL7 DYNC1H1 NIN	1.10e-04	560	136	13	int:TUBB4B
Interaction	EMC9 interactions	MARS1 SMC1A MATR3 RPS18 HP1BP3 ESYT2 RPL7	1.21e-04	163	136	7	int:EMC9
Interaction	PPM1A interactions	ERBB2 GRWD1 RANBP3 RAD50 PPP1R7 MID1 HAO2	1.21e-04	163	136	7	int:PPM1A
Interaction	NOP2 interactions	USP36 GRWD1 NOP53 MATR3 BIRC3 KPNA6 HP1BP3 SMC3 UTP15 RECQL4 RPL7	1.23e-04	416	136	11	int:NOP2
Interaction	FTL interactions	NOP53 SMC1A MYO5C TBC1D31 SMC3 UTP15 RECQL4 ASPM IQGAP3 AGTPBP1	1.29e-04	348	136	10	int:FTL
Interaction	GCN1 interactions	GRWD1 MYO10 SMC1A STK32B BIRC3 SMC3 PRKACA RPL7 DYNC1H1 GPR45	1.32e-04	349	136	10	int:GCN1
Interaction	FBXW10B interactions	FBXW10B FBXW10	1.35e-04	3	136	2	int:FBXW10B
Interaction	SLX4 interactions	USP36 ERCC1 BAZ2B NOP53 RBM10 SMC1A MATR3 RAD50 AP2A2 SMC3 IQGAP3 RPL7 DYNC1H1	1.35e-04	572	136	13	int:SLX4
Interaction	ADAR interactions	USP36 GRWD1 RBM10 SMC1A MATR3 BIRC3 SMC3 RECQL4 LY86	1.43e-04	286	136	9	int:ADAR
Interaction	NIN interactions	CLASP1 RBM10 CNTRL ESYT2 TBC1D31 PRKACA PRKACB RPL7 DYNC1H1 NIN	1.66e-04	359	136	10	int:NIN
Interaction	KRT38 interactions	EPS15 TROAP MYO5C ASPM ATF3 IQGAP3 NIN	1.69e-04	172	136	7	int:KRT38
Interaction	HSPA4 interactions	ERBB2 GRWD1 ATR BIRC3 STAT2 RAD50 PPP1R7 MYH14 PTPRR RPTOR RECQL4 PRKACA ASPM FES	1.70e-04	667	136	14	int:HSPA4
Interaction	RANBP2 interactions	USP36 PPP1R12A MATR3 BIRC3 RAD50 RECQL4 CNTNAP2 PRKACB TRAF3IP3 MYBPC2	1.73e-04	361	136	10	int:RANBP2
Interaction	NECAP1 interactions	EPS15 RAD50 AP2A2 AP1G1 RECQL4	1.85e-04	78	136	5	int:NECAP1
Interaction	CHD4 interactions	USP36 GRWD1 ATR RBM10 PPP1R12A SMC1A MATR3 BIRC3 RPS18 KPNA6 OGG1 HP1BP3 SMC3 DPEP2 RECQL4 PRKACB RPL7	1.97e-04	938	136	17	int:CHD4
Interaction	DCLRE1C interactions	ATR RAD50 PPP2R5E PRKACB	2.00e-04	43	136	4	int:DCLRE1C
Interaction	FGD1 interactions	HP1BP3 ESYT2 SMC3 RPL7	2.18e-04	44	136	4	int:FGD1
Interaction	PDS5A interactions	MARS1 RBM10 SMC1A MATR3 BIRC3 SMC3 CEP112 GPR45	2.63e-04	245	136	8	int:PDS5A
Interaction	SYCP3 interactions	ATR SMC1A SMC3	2.69e-04	19	136	3	int:SYCP3
Interaction	CIT interactions	FBLN7 GRWD1 CLASP1 MARS1 NOP53 RBM10 PPP1R12A SMC1A MATR3 RPS18 CFAP43 HP1BP3 AP2A2 SMC3 UTP15 MYH14 EIF4A2 CNTNAP4 RIC8A RPL7 DYNC1H1 NIN	2.78e-04	1450	136	22	int:CIT
Interaction	MSH2 interactions	ERCC1 ATR SMC1A MATR3 BIRC3 RAD50 AP1G1 SMC3 RECQL4	2.80e-04	313	136	9	int:MSH2
Interaction	ENO1 interactions	ATR PPP1R12A BIRC3 PPP2R5E FBXO5 SMC3 MYH14 PTPRR RPTOR RECQL4 PRKACA DYNC1H1 STX6 AGTPBP1	2.83e-04	701	136	14	int:ENO1
Interaction	BRCA2 interactions	ERCC2 ATR FAAP24 SMC1A RAD50 SMC3 MYH14 TIMELESS DYNC1H1 NIN	2.84e-04	384	136	10	int:BRCA2
Interaction	PRKAR1A interactions	GRWD1 MARS1 BIRC3 AP1G1 RECQL4 PRKACA PRKACB ZBED1 DYNC1H1	2.93e-04	315	136	9	int:PRKAR1A
GeneFamily	WD repeat domain containing	FBXW10B FBXW10 GRWD1 CFAP43 TBC1D31 UTP15 RPTOR WDFY3	3.21e-05	262	85	8	362
GeneFamily	Structural maintenance of chromosomes proteins\|Cohesin complex	SMC1A SMC3	4.52e-04	7	85	2	761
GeneFamily	WD repeat domain containing\|ERCC excision repair associated	ERCC1 ERCC2	4.52e-04	7	85	2	1268
GeneFamily	Cohesin complex	SMC1A SMC3	6.00e-04	8	85	2	1060
GeneFamily	Fibronectin type III domain containing	MID2 MID1 ROBO1 USH2A MYBPC2	9.46e-04	160	85	5	555
GeneFamily	WD repeat domain containing\|F-box and WD repeat domain containing	FBXW10B FBXW10	1.17e-03	11	85	2	559
Coexpression	HALLMARK_MITOTIC_SPINDLE	CLASP1 SMC1A CNTRL SHROOM2 TUBGCP5 FBXO5 SMC3 MID1 DYNC1H1 NIN	1.08e-07	199	138	10	M5893
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	EPS15 TRAF1 ATR NOP53 PPP1R12A MATR3 CNTRL BIRC3 ARHGAP9 RPS18 KPNA6 ICE1 OGG1 ESYT2 TRANK1 PPP2R5E SMC3 EIF4A2 PRKACB TRAF3IP3 RPL7 DYNC1H1 NIN	3.29e-06	1492	138	23	M40023
Coexpression	FAN_EMBRYONIC_CTX_MICROGLIA_1	TROAP SMC1A CNTRL HP1BP3 FBXO5 ASPM IQGAP3	1.87e-05	155	138	7	M39041
Coexpression	KAUFFMANN_DNA_REPAIR_GENES	ERCC1 ERCC2 ATR SMC1A OGG1 RAD50 SMC3 RECQL4	3.10e-05	230	138	8	M11563
Coexpression	SANSOM_APC_TARGETS_REQUIRE_MYC	ERCC1 GRWD1 OGG1 THOP1 ASCL2 TIMELESS METTL2A METTL2B	3.20e-05	231	138	8	MM737
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FBLN7 TROAP FBXO5 RECQL4 ASPM TIMELESS GEN1 IQGAP3	2.27e-07	200	139	8	af3dc76b4507bf4edd265169f5dfbbb8a19eb394
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FBLN7 TROAP FBXO5 RECQL4 ASPM GEN1 IQGAP3	2.06e-06	187	139	7	9351fa87b69a951af85b10bf91fe9b1cce8c0517
ToppCell	Control-Endothelial-Endothelial-FOXM1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TROAP TBC1D31 FBXO5 RECQL4 ASPM GEN1 IQGAP3	2.21e-06	189	139	7	1e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCell	pdx-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	TROAP HP1BP3 CEP112 ASPM TIMELESS GEN1 IQGAP3	2.29e-06	190	139	7	d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCLY IGFALS SPHKAP CNTNAP2 PRKACB ROBO1 USH2A	2.45e-06	192	139	7	5b7093d5af5ae7b0e6d3a464cc56272440ecedad
ToppCell	human_hepatoblastoma-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	TROAP TBC1D31 CEP112 MID1 ASPM GEN1 IQGAP3	2.54e-06	193	139	7	4b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FBLN7 TROAP FBXO5 RECQL4 ASPM TIMELESS IQGAP3	2.90e-06	197	139	7	84ed777cdba569200a3ef1654d8a12f17fcfb7f1
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Deuterosomal\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	FBXW10B FBXW10 CFAP91 RECQL4 ASPM IQGAP3 CFAP99	2.90e-06	197	139	7	861e8df9bd74dc5e17bafdc1fb3fef546753c73a
ToppCell	Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control_saline / Treatment groups by lineage, cell group, cell type	NDNF ERBB2 FRAS1 MYO5C MYH14 PLA2G4B GNG5	3.00e-06	198	139	7	85f424cd9bb3117c9e322031024aabb87696ce47
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NDNF ERBB2 FRAS1 MYO5C MYH14 PLEKHG3 PLA2G4B	3.00e-06	198	139	7	b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	NDNF ERBB2 FRAS1 MYO5C IGFALS MYH14 PLA2G4B	3.10e-06	199	139	7	d43c605a4ff221cf78d91678c15d2ad20f831c7f
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	NDNF ERBB2 FRAS1 MYO5C MYH14 PLA2G4B GNG5	3.10e-06	199	139	7	1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell\|10w / Sample Type, Dataset, Time_group, and Cell type.	TROAP FBXO5 ASPM TIMELESS GNG5 GEN1 IQGAP3	3.21e-06	200	139	7	8f8b8c225cdc79baf16fe04be89bdb65e404a055
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TROAP CNTRL HP1BP3 FBXO5 ASPM GEN1 IQGAP3	3.21e-06	200	139	7	4cfe08878a6981bf7b3567f9e82192d8f060ddde
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells\|10w / Sample Type, Dataset, Time_group, and Cell type.	TROAP FBXO5 ASPM TIMELESS GNG5 GEN1 IQGAP3	3.21e-06	200	139	7	a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	NDNF ERBB2 FRAS1 MYO5C MYH14 PLA2G4B GNG5	3.21e-06	200	139	7	ddfb1f006365bf16203ee49f20200f68220cc288
ToppCell	Non-neuronal-Dividing-IPC-IPC-div2\|World / Primary Cells by Cluster	BAZ2B MYO10 SMC1A FBXO5 SMC3 ASPM TIMELESS	3.21e-06	200	139	7	4923d7a4f00853c4d76fc1cc0fa82d522a2302e7
ToppCell	COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	TROAP SMC1A FBXO5 SMC3 RECQL4 ASPM TIMELESS	3.21e-06	200	139	7	04bf9e6a0fbd792b49eed63dabba5d6fafed8c07
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW12-Stem_cells\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	TROAP MYO10 STOX1 FBXO5 RECQL4 XPNPEP3 GNG5	3.21e-06	200	139	7	4a57d6ba1531ce4e263daccd5de487977e6a1fdd
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW12-Stem_cells-Stem_cells\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	TROAP MYO10 STOX1 FBXO5 RECQL4 XPNPEP3 GNG5	3.21e-06	200	139	7	b706526b9c3485889a31253a1ffd017ad3f3fddc
ToppCell	Non-neuronal-Dividing-IPC-IPC-div2-5\|World / Primary Cells by Cluster	BAZ2B MYO10 SMC1A FBXO5 SMC3 ASPM TIMELESS	3.21e-06	200	139	7	dc1c1506823eaa105f1532c6b5d4efa14e788314
ToppCell	COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	TROAP SMC1A FBXO5 SMC3 RECQL4 ASPM TIMELESS	3.21e-06	200	139	7	f6b5320cdfe640a71e6e2df26f30d42e64b1c921
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular\|TCGA-Stomach / Sample_Type by Project: Shred V9	FBXW10B ATR RECQL4 ASPM GEN1 IQGAP3	4.80e-06	138	139	6	93497c0a5d5e54006653b2dedc7a7041e1a613e6
ToppCell	Severe-B_naive-1\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	FBXW10 NOP53 MATR3 BIRC3 ICE1 USH2A	5.21e-06	140	139	6	683ee5e103f0c68cbbec019249404d381dbc39f3
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FBLN7 HUS1B BAZ2B LDHAL6B MUC12 TBC1D31	5.89e-06	143	139	6	39060dc1d87505a16e2df95140087c731f099570
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DNALI1 GHRHR SLC25A22 ASPM ATF3 IQGAP3	9.34e-06	155	139	6	8b524c65fa5c901f70c7caae4ec7fd2859eaf227
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MID2 FBXO5 PTPRR CASKIN1 ASPM IQGAP3	9.34e-06	155	139	6	8e239470799426ea474a36f57e1b7e0d9365ca5f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_low-phase\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DNALI1 GHRHR SLC25A22 ASPM ATF3 IQGAP3	9.34e-06	155	139	6	7fe8b8c0c8a9e3190cfd52d3934509e6780e1717
ToppCell	COVID-19_Mild-PLT_0\|COVID-19_Mild / Disease Group and Platelet Clusters	TROAP ICE1 CFAP43 GUCY1B1 XPNPEP3 TTC22	1.33e-05	165	139	6	083a14d3b0162cee4e79f7398b8fb739582b39ff
ToppCell	droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TROAP FBXO5 ASPM TIMELESS GEN1 IQGAP3	1.33e-05	165	139	6	96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FBLN7 TROAP FBXO5 RECQL4 ASPM IQGAP3	1.43e-05	167	139	6	bc132b51dec4e8f1cd2b2cd89f83641976e09292
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TROAP TBC1D31 FBXO5 ASPM GEN1 IQGAP3	1.53e-05	169	139	6	e0607af8ae8609d43e26ff2a2cab92650bfcd5b7
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4\|Striatum / BrainAtlas - Mouse McCarroll V32	TROAP FBXO5 RECQL4 ASPM GEN1 IQGAP3	1.92e-05	176	139	6	d70fdc7bc48719776ed1e7c01118385e3a21623f
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1\|Striatum / BrainAtlas - Mouse McCarroll V32	TROAP FBXO5 RECQL4 ASPM GEN1 IQGAP3	1.92e-05	176	139	6	a84361308e5e96f3a30246cd29e109c321ee65bf
ToppCell	367C-Myeloid-Dendritic-cDC_proliferating_1\|367C / Donor, Lineage, Cell class and subclass (all cells)	TROAP FBXO5 RECQL4 ASPM IQGAP3 MYBPC2	1.98e-05	177	139	6	ba701d3c90722d8bff70d0fa651899305cdad257
ToppCell	control-Lymphoid-NKT-proliferating\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	TROAP RPS18 FBXO5 RECQL4 ASPM IQGAP3	2.18e-05	180	139	6	535535a67b3f3320bad2f98b1bc98a7b0ee77840
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FBLN7 TROAP RECQL4 ASPM GEN1 IQGAP3	2.18e-05	180	139	6	f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NDNF ERBB2 FRAS1 MYO5C MYH14 PLA2G4B	2.25e-05	181	139	6	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	droplet-Spleen-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRAF1 NOP53 RPS18 EIF4A2 LY86 RPL7	2.25e-05	181	139	6	14a04d8d69d3054b6ed3370d361dec5303ca4831
ToppCell	cellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC12 DPEP2 ASCL2 TIMELESS TRAF3IP3 TTC22	2.32e-05	182	139	6	8ccffcbae28c374fd4161fb0d4cf2c49fae557f6
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NDNF FRAS1 BIRC3 MYO5C MYH14 PLA2G4B	2.47e-05	184	139	6	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MATR3 CNTRL HP1BP3 EIF4A2 ATF3 LY86	2.47e-05	184	139	6	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FBLN7 TROAP FBXO5 ASPM GEN1 IQGAP3	2.54e-05	185	139	6	30e041d6f6e310d64809e9d6d93cd30052972f3b
ToppCell	facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TROAP TBC1D31 FBXO5 ASPM GEN1 IQGAP3	2.62e-05	186	139	6	9feef5936985e936b3d88f9d1bb012abb6468570
ToppCell	facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TROAP TBC1D31 FBXO5 ASPM GEN1 IQGAP3	2.62e-05	186	139	6	89f5b06bc56674af304912d481ac697c7c870904
ToppCell	ICU-NoSEP-Lymphocyte-T_NK-CD4_TCM\|ICU-NoSEP / Disease, Lineage and Cell Type	NOP53 BIRC3 RPS18 EIF4A2 TRAF3IP3 RPL7	2.70e-05	187	139	6	9856e0ddf989707e2a25ed6ab75bd9fa939c9046
ToppCell	CV-Severe-3\|Severe / Virus stimulation, Condition and Cluster	PPP1R12A MUC12 ASCL2 RECQL4 ASPM FES	2.70e-05	187	139	6	68cb43a73945f5e252530da25613f6b3f484b4d5
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TROAP CNTRL RECQL4 ASPM LY86 IQGAP3	2.70e-05	187	139	6	73931a5ea73799095daff100b5f18853c57c74dc
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FBLN7 TROAP FBXO5 ASPM TIMELESS IQGAP3	2.87e-05	189	139	6	fd8834d1feb7f63911c5fa51efb1f679a8baddeb
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TROAP CNTRL HP1BP3 FBXO5 ASPM IQGAP3	2.95e-05	190	139	6	cd37ccd30c27cf65eda0a9165f35b7672f5acaf6
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	TROAP TBC1D31 FBXO5 ASPM GEN1 IQGAP3	3.04e-05	191	139	6	0ba5b112a82e489f5a21966f78a403a7436ce73b
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TROAP TBC1D31 FBXO5 ASPM GEN1 IQGAP3	3.13e-05	192	139	6	27723f4e320e49d4a3daafa2d8d3946ff79fab64
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	ACADVL TROAP KPNA6 HP1BP3 RECQL4 ASPM	3.13e-05	192	139	6	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LDHAL6B ARHGAP9 RPS18 PRKACB ASPM RPL7	3.22e-05	193	139	6	91a1c9b8390cbd881db8c49d8f34feca0d1067d6
ToppCell	ILEUM-inflamed-(1)_Central_Memory_T_cells\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TRAF1 NOP53 BIRC3 RPS18 EIF4A2 RPL7	3.22e-05	193	139	6	c4975fff8927649669e93d3e04308cbf4a48e3e9
ToppCell	PCW_07-8.5\|World / Celltypes from embryonic and fetal-stage human lung	RPS18 RAD50 FBXO5 ASPM GNG5 NIN	3.32e-05	194	139	6	5759c83308df017f1faae248e9b85388e25254f0
ToppCell	ILEUM-inflamed-(1)_T_cell-(1)_Central_Memory_T_cells\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TRAF1 NOP53 BIRC3 RPS18 EIF4A2 RPL7	3.42e-05	195	139	6	0a200e43e861d5a24c07244c576bba5d67efcf2d
ToppCell	distal-Hematologic-B_cell\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NOP53 BIRC3 RPS18 CNTNAP2 CNTNAP4 TRAF3IP3	3.52e-05	196	139	6	dfd2870c30b246b23bc1b3f9ad7b5d8b121238df
ToppCell	normal_Pleural_Fluid-T/NK_cells-Naive_CD4+_T\|T/NK_cells / Location, Cell class and cell subclass	FBLN7 NOP53 BIRC3 RPS18 EIF4A2 RPL7	3.52e-05	196	139	6	5958caed4172ca478a6d9112d50af9070c850b96
ToppCell	distal-Hematologic-B_cell-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NOP53 BIRC3 RPS18 CNTNAP2 TRAF3IP3 RPL7	3.62e-05	197	139	6	cc1567c3c539edc152118fb957617f8d445132d9
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FBLN7 TROAP FBXO5 ASPM TIMELESS IQGAP3	3.62e-05	197	139	6	8b616cde333bdbc0c591035ad9e4949155866245
ToppCell	COVID_vent-Lymphocytic\|COVID_vent / Disease condition, Lineage, Cell class and subclass	NOP53 BIRC3 RPS18 TRANK1 EIF4A2 PRKACB	3.72e-05	198	139	6	ee80f647317377081b4bd194ee2801f556b3a53b
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	TROAP FBXO5 RECQL4 ASPM TIMELESS IQGAP3	3.72e-05	198	139	6	6a10bb81817ab606f1f5a2bd8cfe77ef2fb3f2fb
ToppCell	distal-1-Hematologic-Proliferating_Macrophage\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TROAP FBXO5 RECQL4 ASPM TIMELESS IQGAP3	3.72e-05	198	139	6	df3f5559ecd1f3cd1fd60e39dbad8741309e83a3
ToppCell	distal-Hematologic-Proliferating_Macrophage-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TROAP FBXO5 RECQL4 ASPM TIMELESS IQGAP3	3.72e-05	198	139	6	2b0716e900bce54ad1825d6dcdaf4ebf31f355c4
ToppCell	Control_saline-Epithelial_alveolar-AT_1\|Control_saline / Treatment groups by lineage, cell group, cell type	NDNF ERBB2 FRAS1 MYO5C MYH14 GNG5	3.72e-05	198	139	6	9b161285df7a4e51618f3517cfc5b8221ba55786
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TROAP FBXO5 RECQL4 ASPM GEN1 IQGAP3	3.72e-05	198	139	6	f088badb90c6c2d916195f5649eda102119c9ac6
ToppCell	cycling_basal_cell\|World / shred by cell class for turbinate	TROAP FBXO5 RECQL4 ASPM TIMELESS IQGAP3	3.72e-05	198	139	6	e86c1224f5b0890a50a25257628e90c790aae7cd
ToppCell	367C-Myeloid-Dendritic-cDC_proliferating_1\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	TROAP MATR3 FBXO5 RECQL4 ASPM TIMELESS	3.83e-05	199	139	6	3d876f172487425b37b2f658dae59e0f293ee76e
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-RGCs_early_1\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	MYO10 RPS18 MID1 CNTNAP2 GNG5 RPL7	3.83e-05	199	139	6	afed9fefd1355eb3bc17fbc7ce04daad890a0f9f
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	FBLN7 TROAP FBXO5 ASPM TIMELESS IQGAP3	3.83e-05	199	139	6	a99516a5760f49a69b0fe45a9b2316e393252966
ToppCell	Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	FBLN7 TROAP RECQL4 ASPM TIMELESS IQGAP3	3.83e-05	199	139	6	4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_dorsal_progenitors\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	TROAP CNTRL FBXO5 ASPM GNG5 IQGAP3	3.83e-05	199	139	6	ca17e8c0f5bc2c41ce28351a7418d934404e563b
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	BAZ2B MATR3 CNTRL RAD50 PPP2R5E SMC3	3.83e-05	199	139	6	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NDNF ERBB2 FRAS1 MYO5C MYH14 PLA2G4B	3.83e-05	199	139	6	a270630626df614f8605abddb7dee7c4d74f6149
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	BAZ2B MATR3 BIRC3 RAD50 PPP2R5E SMC3	3.83e-05	199	139	6	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	MYO10 RPS18 MID1 CNTNAP2 GNG5 RPL7	3.83e-05	199	139	6	3c9bd4d4b166788f807eaaf4f74735949031c295
ToppCell	Dividing_Macrophages\|World / lung cells shred on cell class, cell subclass, sample id	TROAP FAAP24 FBXO5 RECQL4 ASPM IQGAP3	3.83e-05	199	139	6	5c755b6876e164dc847ef7c723f850f227cf3a87
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-FOXM1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	TROAP CNTRL FBXO5 ASPM GEN1 IQGAP3	3.83e-05	199	139	6	98575fcce726589e93fbb4df1aab03e57cb56076
ToppCell	LPS_IL1RA-Endothelial-Endothelial-FOXM1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TROAP CNTRL FBXO5 ASPM GEN1 IQGAP3	3.83e-05	199	139	6	be2276c9a1994579ba1d2998b49bf549c1324d44
ToppCell	distal-Hematologic-Proliferating_Macrophage\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TROAP FBXO5 RECQL4 ASPM TIMELESS IQGAP3	3.93e-05	200	139	6	3835a8a9739b8cd5bf19c40765ef76907ac1ad38
ToppCell	Biopsy_IPF-Epithelial-Proliferating_Epithelial_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	TROAP FBXO5 RECQL4 ASPM TIMELESS IQGAP3	3.93e-05	200	139	6	63c5402f050fdb12abab3c8b7f33d4914ae26b9b
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-OPC_related\|5w / Sample Type, Dataset, Time_group, and Cell type.	MYO10 NOP53 SIL1 ASCL2 GNG5 RPL7	3.93e-05	200	139	6	b19a75d4f23e9685cbb6c6fa873d7726f27bd5f2
ToppCell	Control_saline-Endothelial-Endothelial-FOXM1\|Control_saline / Treatment groups by lineage, cell group, cell type	TROAP CNTRL FBXO5 ASPM GEN1 IQGAP3	3.93e-05	200	139	6	9bbc7b5561151f6ff65f40b3226271def732e5d9
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Interneuron\|3m / Sample Type, Dataset, Time_group, and Cell type.	SYT17 MATR3 RPS18 SHROOM2 PTPRR RPL7	3.93e-05	200	139	6	a313b9a8bde1ea80a6eae183b76fba46b86558b4
ToppCell	Biopsy_Control_(H.)-Immune-Proliferating_Macrophages\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	TROAP FBXO5 RECQL4 ASPM GEN1 IQGAP3	3.93e-05	200	139	6	ce9fad55f779afd3d6c5a9c5a15e2d9f548b7c7e
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	NDNF ERBB2 FRAS1 MYO5C MYH14 PLA2G4B	3.93e-05	200	139	6	8683445ad5b70748c4a1f12eb77d47623085147e
ToppCell	Sepsis-URO-Lymphocyte-T/NK-T/NK_proliferative\|URO / Disease, condition lineage and cell class	TROAP FBXO5 RECQL4 ASPM TIMELESS IQGAP3	3.93e-05	200	139	6	f277db6cc288a52a5426120c1067608700ee8ccc
ToppCell	VE-CD4\|VE / Condition, Cell_class and T cell subcluster	FBLN7 NOP53 BIRC3 RPS18 TRAF3IP3 RPL7	3.93e-05	200	139	6	f3b778b1f20c2b1e6d623df776e470a57cb1a842
ToppCell	Biopsy_Other_PF-Immune-Proliferating_Macrophages\|Biopsy_Other_PF / Sample group, Lineage and Cell type	TROAP FBXO5 RECQL4 ASPM TIMELESS IQGAP3	3.93e-05	200	139	6	61473e8613f39a92002d5b631e6bd563735566e4
ToppCell	tumor_Lymph_Node_/_Brain-B_lymphocytes-Follicular_B_cells\|B_lymphocytes / Location, Cell class and cell subclass	NOP53 BIRC3 RPS18 EIF4A2 LY86 RPL7	3.93e-05	200	139	6	343fb063ba9f31ce3758854d3387876553177551
ToppCell	distal-3-Hematologic-Proliferating_Macrophage\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TROAP FBXO5 RECQL4 ASPM GEN1 IQGAP3	3.93e-05	200	139	6	1b65c97e8123d0572d31525d6a10bc7f16857959
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-OPC_related-Oligodendrocyte/OPC\|5w / Sample Type, Dataset, Time_group, and Cell type.	MYO10 NOP53 SIL1 ASCL2 GNG5 RPL7	3.93e-05	200	139	6	b99dc49b735430a5ac51159575b904020d861927
ToppCell	Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	NR2F6 FBXW10 ARHGAP9 LY86 IQGAP3	4.92e-05	127	139	5	0750743574c2fca8df07e11d73e8b94579209609
ToppCell	LPS-antiTNF-Unknown\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EFCAB5 TROAP ASPM GEN1 IQGAP3	5.30e-05	129	139	5	739b263296c28554967362060b154f7a95e1341d
ToppCell	LPS-antiTNF-Unknown-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EFCAB5 TROAP ASPM GEN1 IQGAP3	5.50e-05	130	139	5	615c233c7c2600c1c2bc5cf5b1c501fc474564ef
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-1\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NOP53 MATR3 BIRC3 CLCN4 CNTNAP2	5.70e-05	131	139	5	a3a086ce6e69707ca6a042f3b15c130f81909acb
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial-new-cluster\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP36 RPS18 LCN10 GNG5 USH2A	6.35e-05	134	139	5	dd0144af4f78d3483f129f908aadb1d67002aa9f
ToppCell	IIH-CD4-proli_CD4\|IIH / Condition, Cell_class and T cell subcluster	FBLN7 FBXW10 BIRC3 RPS18 RPL7	7.30e-05	138	139	5	e474a0785a651020156baacbf89c4d2b1e4cc473
ToppCell	droplet-Bladder-nan-3m-Hematologic-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFCAB5 NR2F6 ARHGAP9 LY86 IQGAP3	1.12e-04	151	139	5	a7b1a60d68f0ed17022fe4c97af64f9f08d39fa3
Drug	chlorpromazine hydrochloride; Down 200; 1uM; PC3; HT_HG-U133A	GRWD1 CLASP1 BAZ2B RAD50 SLC25A22 PTPRR PLEKHG3 PRKACA STX6	2.93e-06	194	138	9	1217_DN
Drug	Acetazolamide [59-66-5]; Down 200; 18uM; HL60; HT_HG-U133A	CLASP1 SMC1A OGG1 STAT2 SLC25A22 XPNPEP3 OTUD3 WDFY3 STX6	3.46e-06	198	138	9	1850_DN
Drug	riccardin D	ERCC1 ERCC2 ATR SMC1A OGG1 RAD50	6.86e-06	76	138	6	ctd:C547185
Drug	myristicin	ERCC1 ERCC2 SMC1A OGG1 RAD50	7.65e-06	45	138	5	ctd:C005246
Drug	sebacate	ERCC1 ERCC2 ATR ACADVL OGG1 RAD50 SMC3 RECQL4	1.50e-05	181	138	8	CID000005192
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	USP36 ERBB2 TROAP BIRC3 HP1BP3 THOP1 AP2A2 XPNPEP3	2.06e-05	189	138	8	1206_DN
Drug	Cinchonine [118-10-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A	NR2F6 FRAS1 MARS1 SYT17 RANBP3 SMC1A PRKACA TIMELESS	2.22e-05	191	138	8	2789_DN
Drug	Tadjakonine [11087-94-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	MARS1 SMC1A CNTRL DNALI1 AP2A2 PLEKHG3 PRKACA TIMELESS	2.57e-05	195	138	8	2820_DN
Drug	Zardaverine [101975-10-4]; Down 200; 15uM; MCF7; HT_HG-U133A	RBM10 RANBP3 FAAP24 HP1BP3 PPP1R7 AP2A2 PRKACA SNAPC2	2.67e-05	196	138	8	4793_DN
Drug	Fluocinonide [356-12-7]; Up 200; 8uM; MCF7; HT_HG-U133A	ERCC2 BIRC3 PIWIL2 STAT2 GHRHR IGFALS CEP112 HAO2	2.67e-05	196	138	8	3933_UP
Drug	Diethylstilbestrol [56-53-1]; Down 200; 15uM; PC3; HT_HG-U133A	SYT17 RANBP3 FAAP24 SMC1A CNTRL H6PD AP2A2 STX6	2.77e-05	197	138	8	4547_DN
Drug	Meptazinol hydrochloride [59263-76-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A	NR2F6 ERCC1 MID2 MARS1 RANBP3 FAAP24 HP1BP3 WDFY3	2.98e-05	199	138	8	7326_DN
Drug	sulfo-MBS	ERBB2 PPP1R12A EGF	3.47e-05	11	138	3	CID000124851
Disease	Prostatic Neoplasms	ERBB2 TRAF1 ERCC2 ATR OGG1 SIL1 EGF MYH14 PRKACB ROBO1 ATF3 GNG5 ZBED1	5.85e-06	616	136	13	C0033578
Disease	Malignant neoplasm of prostate	ERBB2 TRAF1 ERCC2 ATR OGG1 SIL1 EGF MYH14 PRKACB ROBO1 ATF3 GNG5 ZBED1	5.85e-06	616	136	13	C0376358
Disease	high grade glioma (is_implicated_in)	ERBB2 ERCC1 ERCC2 EGF	4.22e-05	42	136	4	DOID:3070 (is_implicated_in)
Disease	Pena Shokeir syndrome Type 2	ERCC1 ERCC2	6.31e-05	3	136	2	C2931277
Disease	CAMFAK syndrome	ERCC1 ERCC2	6.31e-05	3	136	2	C1859312
Disease	lung adenocarcinoma (is_implicated_in)	ERBB2 RBM10 EGF FES	7.79e-05	49	136	4	DOID:3910 (is_implicated_in)
Disease	Cerebrooculofacioskeletal Syndrome 1	ERCC1 ERCC2	1.26e-04	4	136	2	C0220722
Disease	Intrahepatic Cholangiocarcinoma	ERBB2 PRKACA PRKACB	1.81e-04	24	136	3	C0345905
Disease	Extrahepatic Cholangiocarcinoma	ERBB2 PRKACA PRKACB	1.81e-04	24	136	3	C3805278
Disease	Alzheimer's disease (is_marker_for)	ERCC2 ATR ACADVL STOX1 EGF GUCY1B1 DYNC1H1	1.97e-04	257	136	7	DOID:10652 (is_marker_for)
Disease	Congenital muscular hypertrophy-cerebral syndrome	SMC1A SMC3	2.09e-04	5	136	2	C1802395
Disease	Cornelia de Lange Syndrome 3	SMC1A SMC3	2.09e-04	5	136	2	C1853099
Disease	Cornelia de Lange Syndrome 1	SMC1A SMC3	2.09e-04	5	136	2	C4551851
Disease	Cholangiocarcinoma	ERBB2 PRKACA PRKACB	2.30e-04	26	136	3	C0206698
Disease	De Lange syndrome	SMC1A SMC3	3.13e-04	6	136	2	cv:C0270972
Disease	Biliary Tract Neoplasm	ERBB2 PRKACB	3.13e-04	6	136	2	C0005426
Disease	Opitz GBBB syndrome (implicated_via_orthology)	MID2 MID1	3.13e-04	6	136	2	DOID:0080697 (implicated_via_orthology)
Disease	Cornelia de Lange syndrome (implicated_via_orthology)	SMC1A SMC3	3.13e-04	6	136	2	DOID:11725 (implicated_via_orthology)
Disease	bowel opening frequency	FFAR3 MUC12 FBXO24	3.55e-04	30	136	3	EFO_0600084
Disease	smoking status measurement, low density lipoprotein cholesterol measurement	ASCL2 CNTNAP2	4.36e-04	7	136	2	EFO_0004611, EFO_0006527
Disease	Urologic Neoplasms	ATR OGG1	5.80e-04	8	136	2	C0042076
Disease	Cancer of Urinary Tract	ATR OGG1	5.80e-04	8	136	2	C0751571
Disease	autosomal recessive intellectual developmental disorder (implicated_via_orthology)	CNTNAP2 CNTNAP4	5.80e-04	8	136	2	DOID:0060308 (implicated_via_orthology)
Disease	head and neck squamous cell carcinoma (is_marker_for)	ERBB2 OGG1	5.80e-04	8	136	2	DOID:5520 (is_marker_for)
Disease	Cornelia De Lange Syndrome	SMC1A SMC3	5.80e-04	8	136	2	C0270972
Disease	Xeroderma pigmentosum	ERCC1 ERCC2	7.43e-04	9	136	2	cv:C0043346
Disease	ovary epithelial cancer (is_implicated_in)	ERCC1 ERCC2	1.13e-03	11	136	2	DOID:2152 (is_implicated_in)
Disease	senile cataract (is_implicated_in)	ERCC2 OGG1	1.13e-03	11	136	2	DOID:9669 (is_implicated_in)
Disease	visual epilepsy (is_implicated_in)	CNTNAP2 ASPM	1.13e-03	11	136	2	DOID:11832 (is_implicated_in)
Disease	congenital left-sided heart lesions	FRAS1 CFAP43 GHRHR	1.42e-03	48	136	3	EFO_0005938
Disease	hepatocellular carcinoma (is_implicated_in)	ERCC2 BIRC3 EGF SMC3 FES	1.55e-03	181	136	5	DOID:684 (is_implicated_in)
Disease	Nephronophthisis	NPHP3 XPNPEP3	1.59e-03	13	136	2	C0687120
Disease	pancreatic cancer (is_implicated_in)	ERCC1 ERCC2 ATR OGG1	1.83e-03	112	136	4	DOID:1793 (is_implicated_in)
Disease	autosomal dominant polycystic kidney disease (implicated_via_orthology)	NPHP3 PKD1	1.85e-03	14	136	2	DOID:898 (implicated_via_orthology)
Disease	Carcinoma, Granular Cell	ERBB2 OGG1 EGF ROBO1	2.07e-03	116	136	4	C0205644
Disease	Adenocarcinoma, Tubular	ERBB2 OGG1 EGF ROBO1	2.07e-03	116	136	4	C0205645
Disease	Adenocarcinoma, Oxyphilic	ERBB2 OGG1 EGF ROBO1	2.07e-03	116	136	4	C0205642
Disease	Carcinoma, Cribriform	ERBB2 OGG1 EGF ROBO1	2.07e-03	116	136	4	C0205643
Disease	Adenocarcinoma, Basal Cell	ERBB2 OGG1 EGF ROBO1	2.07e-03	116	136	4	C0205641
Disease	Adenocarcinoma	ERBB2 OGG1 EGF ROBO1	2.07e-03	116	136	4	C0001418
Disease	glycerol-3-phosphate measurement	CFAP43 CNTNAP2	2.13e-03	15	136	2	EFO_0010488
Disease	glucose homeostasis measurement, glucose effectiveness measurement	MYO5C MYH14	2.13e-03	15	136	2	EFO_0006833, EFO_0006896
Disease	Chromosome Aberrations	ERCC1 OGG1	2.43e-03	16	136	2	C0008625
Disease	Autosome Abnormalities	ERCC1 OGG1	2.43e-03	16	136	2	C0004403
Disease	Liver carcinoma	TROAP IGFALS EGF ASPM CNTNAP4 ROBO1 HAO2 IQGAP3	2.49e-03	507	136	8	C2239176
Disease	multiple myeloma (is_implicated_in)	ERCC1 ERCC2 ROBO1	2.58e-03	59	136	3	DOID:9538 (is_implicated_in)
Disease	Adenocarcinoma of lung (disorder)	ERBB2 ERCC1 GRWD1 ATR OGG1	2.72e-03	206	136	5	C0152013
Disease	Benign neoplasm of stomach	ERBB2 ATR	2.74e-03	17	136	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	ERBB2 ATR	2.74e-03	17	136	2	C0496905
Disease	Carcinoma in situ of stomach	ERBB2 ATR	2.74e-03	17	136	2	C0154060
Disease	major depressive disorder (is_implicated_in)	TPH2 CNTNAP2	2.74e-03	17	136	2	DOID:1470 (is_implicated_in)
Disease	Charcot-Marie-Tooth disease type 2	MARS1 DYNC1H1	2.74e-03	17	136	2	cv:C0270914
Disease	Myeloid Leukemia	SMC1A SMC3	3.07e-03	18	136	2	C0023470
Disease	Leukemia, Monocytic, Chronic	SMC1A SMC3	3.07e-03	18	136	2	C0023466
Disease	disease free survival	ICE1 CNTNAP2	3.07e-03	18	136	2	EFO_0000409
Disease	Parkinson's disease (is_marker_for)	ERBB2 OGG1 EGF	3.70e-03	67	136	3	DOID:14330 (is_marker_for)
Disease	lung non-small cell carcinoma (is_implicated_in)	ERCC1 ERCC2 BIRC3 EGF	3.98e-03	139	136	4	DOID:3908 (is_implicated_in)
Disease	Malignant neoplasm of breast	NR2F6 ERBB2 LDHAL6B H6PD SHROOM2 EGF EIF4A2 ROBO1 RIC8A TIMELESS GEN1 GPR45	4.14e-03	1074	136	12	C0006142
Disease	Stomach Carcinoma	ERBB2 ATR	4.18e-03	21	136	2	C0699791
Disease	esophagus adenocarcinoma (is_implicated_in)	ERCC1 BIRC3	4.18e-03	21	136	2	DOID:4914 (is_implicated_in)
Disease	stomach cancer (is_implicated_in)	ERBB2 ERCC1 ERCC2	4.53e-03	72	136	3	DOID:10534 (is_implicated_in)
Disease	transitional cell carcinoma (is_implicated_in)	OGG1 RAD50	4.59e-03	22	136	2	DOID:2671 (is_implicated_in)
Disease	Nasopharyngeal carcinoma	ERBB2 ERCC1	4.59e-03	22	136	2	C2931822

Protein segments in the cluster

Peptide	Gene	Start	Entry
LGLRAFIRKQINNIF	PPP2R5E	211	Q16537
NVIIRSQFDGIKRKQ	C21orf140	11	B9A014
DLSVFQNLQVIRGRI	ERBB2	421	P04626
KRQIILDLQISFVGN	ESYT2	261	A0FGR8
RFQLNLTIQILLKQG	CFAP43	1431	Q8NDM7
LQNLLRQKGEQFRLE	CNTRL	1046	Q7Z7A1
AQEIARQAAQIKLLR	BAZ2B	891	Q9UIF8
ISQRRFLVGILKQLN	FBXW10	51	Q5XX13
NSQRKQQLVELGLLR	CEP112	741	Q8N8E3
LIQRLGKQVNFTVDE	CNTNAP4	276	Q9C0A0
YLIRIKGQEFIRQVQ	BIRC3	321	Q13489
RAIKANVFVQLPRLQ	IGFALS	231	P35858
IGFAQRRELILAIKN	CLCN4	646	P51793
ILQLNNNKIRELRAG	CHAD	151	O15335
ARNRALNGDLVVVKL	DIS3L2	101	Q8IYB7
QQRFVDGALRLDQLK	DIS3L2	541	Q8IYB7
FESGNLRKVIQIRKN	AGTPBP1	716	Q9UPW5
NIQGLLKVALDNARI	DACH2	461	Q96NX9
RQVFLRQKSAALIIQ	ASPM	3046	Q8IZT6
QLLQIGLKSEFRQNL	AP2A2	721	O94973
VIYLQKLLRGRVVQN	CFAP91	496	Q7Z4T9
NRVKLVNLGFQALRQ	ASCL2	61	Q99929
LKNALQRAVERGQLE	HP1BP3	301	Q5SSJ5
VFGQNLRDRVKLINE	RANBP3	261	Q9H6Z4
VRVIKDKQTQLNRGF	RBM10	331	P98175
QVRAFQEQVDKLGRL	NR2F6	281	P10588
QIRLQFRDVNGELIA	RAD50	81	Q92878
RVLAINILGRFLLNN	AP1G1	306	O43747
ISQRRFLVGILKQLN	FBXW10B	51	O95170
RERVQGSKQQLRLQF	CFAP99	261	D6REC4
AIRQLQQLLKGQETR	FBLN7	36	Q53RD9
RLLLQAGIDINRQTK	CASKIN1	206	Q8WXD9
KIVQVALNGLENILR	KPNA6	436	O60684
RNLLQVDLTKRFGNL	PRKACA	271	P17612
FLKTQGRREVQALLA	PIP5KL1	151	Q5T9C9
QELFRLRGIKAQVAL	NOP53	366	Q9NZM5
IAILNIKVIRRGDQN	FRAS1	3056	Q86XX4
QRGKNLRYQLLQLVE	MATR3	406	P43243
QLKSNINIRFGIILR	LY86	61	O95711
EKGQVEVFALRRLLQ	GRWD1	171	Q9BQ67
RGINIRVFLEAQKQR	ITPRID1	176	Q6ZRS4
KQLEILNFRNGSVIV	IMPG1	621	Q17R60
GKNFALRVLLVQVDV	ERCC1	161	P07992
AVLQFGNIALKRERN	MYH14	371	Q7Z406
KGETRLNLVQRNVAI	LDHAL6B	151	Q9BYZ2
RIAAQRKILAAQGQL	SLC25A22	136	Q9H936
KVQNLVDRRLQVNRG	METTL2B	341	Q6P1Q9
AAIVFQKQLRGQIAR	MYO10	791	Q9HD67
QIQVRRDGKLLLSQN	NDNF	386	Q8TB73
GILENIQRNKLLFIE	ERCC2	556	P18074
KKVVQQLRLEAGLNR	GNG5	11	P63218
QLRLEAGLNRVKVSQ	GNG5	16	P63218
IFQLIDGKVTVRNNI	TUBGCP5	286	Q96RT8
ILRVLGSNVREFLQN	GUCY1B1	86	Q02153
KVNKVGQLRVLLAFR	LCN10	71	Q6JVE6
RKQVVAAALRQALQL	PLA2G4B	271	P0C869
QEVAQKFQGVRLLRQ	OGG1	121	O15527
RKVLQLLRLRQIFNG	RPL7	106	P18124
DRFLIIVQRQDKLNP	GPR45	131	Q9Y5Y3
QLQARLRGFLVRQKF	IQGAP3	736	Q86VI3
KVQNLVDRRLQVNRG	METTL2A	341	Q96IZ6
NKLNITLLRIFRQGV	PTPRR	126	Q15256
FANQLQALGLKLREV	OTUD3	56	Q5T2D3
LAKEVQNGRLFRLLA	PAN3	771	Q58A45
FQVRQRLLLEAIFQK	EFCAB5	866	A4FU69
TLGKQLNVNRREILI	ATR	1016	Q13535
ARARTLNILKGNIQL	ICE1	1761	Q9Y2F5
RNLLQVDLTKRFGNL	PRKACB	271	P22694
VDLERQLLQRVFLNG	EGF	91	P01133
KEIIARGNFRLQNII	FBXO5	221	Q9UKT4
LVRVRNSNNLKGIVV	FAAP24	76	Q9BTP7
LNLLALVVFVGKLQR	FFAR3	31	O14843
ERNLFIQQIKEGTLQ	ATF3	166	P18847
NFGLFLNIIRILVRK	GHRHR	296	Q02643
LDLKLQQRQARETGI	DNALI1	106	O14645
RELAQQIQKVILALG	EIF4A2	111	Q14240
FKQIVLVGQETQRAL	FBXO24	246	O75426
VDNRKLLQFLEGQQI	HUS1B	231	Q8NHY5
IQILKGQSLLQRFNR	GEN1	226	Q17RS7
ALLVQIRKARGTFDN	DYNC1H1	1081	Q14204
LRQVYQKGLQDVNLR	DPEP2	96	Q9H4A9
GNLLRVFRQVEKVQE	DPEP2	391	Q9H4A9
RVQFNQIAPLKAALR	CNTNAP2	1181	Q9UHC6
GILNKQEFFVALRLV	EPS15	66	P42566
VAQILPFRDQNRKAL	H6PD	211	O95479
RLTKIEGLQNLVNLR	PPP1R7	241	Q15435
FLLLVKAAQQLRFVR	PKD1	3996	P98161
VQLLGKRQVLQEALQ	FES	351	P07332
NFIVEQKENGRALLL	USH2A	4071	O75445
IIKELNRRGVLANAL	UTP15	396	Q8TED0
NKFLIGLELVQERQL	SPHKAP	176	Q2M3C7
NRQLLNERIKLEGII	SMC3	811	Q9UQE7
KRILIQAQRAQLEQG	STAT2	116	P52630
RKLNIRQSVGIQKVF	TBC1D31	161	Q96DN5
GRLNVDVIRAKQLLQ	SYT17	336	Q9BSW7
LQFRLLENKIGVLQN	TDO2	156	P48775
RVAQLQDIARQKLLG	TDRD9	1311	Q8NDG6
REQILQQAGKQRLEL	NIN	441	Q8N4C6
RELESKLQRLQAQGI	NPHP3	191	Q7Z494
QQGRVRNLREKFQAL	PLEKHG3	1201	A1L390
KLLVGNIVITRYNNR	PIWIL2	411	Q8TC59
LLQGKRFQNLDSIII	RECQL4	691	O94761
QLNKQLIQRVESLGF	HAO2	136	Q9NYQ3
VRLNLQTGEREAKLQ	SIL1	91	Q9H173
GDRQSLLEKQRVLIQ	SHROOM2	1526	Q13796
VQALAERKNRQALLG	STX6	111	O43752
VAFGQTKDIIRQILQ	SLC25A44	161	Q96H78
TDVRQQLFQELKGVR	RIC8A	176	Q9NPQ8
IQKGITRLDDQIFLN	RPTOR	1006	Q8N122
ELQLQANFLGNVKRL	SERPINA9	141	Q86WD7
KGIVNEQFLLQRLAD	ACADVL	556	P49748
ALVTRLQDRFKAQIG	CLASP1	76	Q7Z460
GKTLRIQQREQLQRA	TRAF3IP3	46	Q9Y228
ENEQFQQLLRKLGVR	TIMELESS	1056	Q9UNS1
QRIKALNQERVAAGL	SCLY	211	Q96I15
RQFILERNAINGIKT	ZNF826P	86	Q6ZT77
FIIQLIAQSKRRSQG	WDFY3	2071	Q8IZQ1
VILDGLKRRQNFLQN	STOX1	951	Q6ZVD7
DGLKRNVTLQNIIDR	MID1	71	O15344
KIQRIGILQQLLRQE	TROAP	431	Q12815
ILIKARNFLVFQGAV	SMC1A	126	Q14683
EGKLRVFENIVAVLN	TRAF1	191	Q13077
GNLAVVQKLRFLVDR	ARHGAP9	581	Q9BRR9
RIKQLENGVLQIRYA	ROBO1	501	Q9Y6N7
LNTNIDGRRKIAFAI	RPS18	16	P62269
GLVKALRLFQEKRVN	TPH2	76	Q8IWU9
LAQLRRQLEQKVAGD	SEC16B	701	Q96JE7
NKVRGVQQLIQRLRL	XPNPEP3	231	Q9NQH7
EFIIFNREKLRRQQG	STK32B	361	Q9NY57
LQRLKEQQFVIAGVL	ZBED1	361	O96006
DGLKRNVTLQNIIDR	MID2	91	Q9UJV3
NFLKQEVVQRFLRLL	TRANK1	351	O15050
NTGLFNLRQIVLAKV	THOP1	546	P52888
LKLQREGLRQELQLA	TTC22	46	Q5TAA0
QQLLKRGFVLQDTVE	MARS1	371	P56192
LQQLKGRVAREAIQK	SNAPC2	66	Q13487
RQAANIVRALELFVK	USP36	276	Q9P275
GKSFRLILNVQVQRK	ZNF560	271	Q96MR9
VNIRRLLNGSIVVKN	MUC12	5221	Q9UKN1
LVRQAVKQLFFLIGA	MYO5C	1571	Q9NQX4
LRQTYIRKVGEQLNL	MYBPC2	846	Q14324
NQRLKDENGALIRVI	PPP1R12A	1011	O14974